Mersana Therapeutics

Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat cancer patients. Leveraging decades of industry experience, we have developed proprietary and highly differentiated ADC platforms and expertise to rapidly design and test novel ADCs, identifying those with optimal efficacy, safety, and tolerability. Using this strategy, we are building a robust pipeline of ADC candidates with the potential to transform the lives of cancer patients.